Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial
Controversies in the management of rare gynecologic cancers
Controversies in the management of Serous Borderline Tumors and Low-Grade Serous Ovarian Cancer
Controversies in the organization and structure of management for rare tumors
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy
Ovarian clear cell carcinoma: open questions on the management and treatment algorithm
PFMG2025 - integrating genomic medicine into the national healthcare system in France
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial
Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma
Next
Next